INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 119 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $18,000 | -50.0% | 16,200 | +0.6% | 0.00% | – |
| Q4 2021 | $36,000 | -34.5% | 16,100 | 0.0% | 0.00% | – |
| Q3 2021 | $55,000 | +14.6% | 16,100 | 0.0% | 0.00% | – |
| Q2 2021 | $48,000 | -86.5% | 16,100 | -85.4% | 0.00% | – |
| Q1 2017 | $355,000 | +136.7% | 110,000 | -1.2% | 0.00% | – |
| Q4 2016 | $150,000 | -14.3% | 111,300 | -0.8% | 0.00% | – |
| Q3 2016 | $175,000 | +17.4% | 112,210 | 0.0% | 0.00% | – |
| Q2 2016 | $149,000 | -59.2% | 112,210 | +62.1% | 0.00% | – |
| Q1 2016 | $365,000 | -32.8% | 69,210 | 0.0% | 0.00% | – |
| Q4 2015 | $543,000 | -19.0% | 69,210 | -12.7% | 0.00% | -100.0% |
| Q3 2015 | $670,000 | -57.6% | 79,310 | -45.0% | 0.00% | 0.0% |
| Q2 2015 | $1,580,000 | +42.3% | 144,330 | +81.8% | 0.00% | 0.0% |
| Q1 2015 | $1,110,000 | -17.2% | 79,400 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,341,000 | +25.8% | 79,400 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,066,000 | +1.0% | 79,400 | -4.1% | 0.00% | 0.0% |
| Q2 2014 | $1,055,000 | +7.2% | 82,800 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $984,000 | -18.9% | 82,800 | -5.8% | 0.00% | 0.0% |
| Q4 2013 | $1,214,000 | -27.3% | 87,900 | -8.1% | 0.00% | -50.0% |
| Q3 2013 | $1,669,000 | -7.3% | 95,662 | -13.6% | 0.00% | 0.0% |
| Q2 2013 | $1,800,000 | – | 110,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |